BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21872827)

  • 1. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
    Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
    Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
    Valleley EM; Cordery SF; Bonthron DT
    Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.
    Lemeta S; Jarmalaite S; Pylkkänen L; Böhling T; Husgafvel-Pursiainen K
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):860-7. PubMed ID: 17805016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent loss of heterozygosity at 6q in pheochromocytoma.
    Lemeta S; Salmenkivi K; Pylkkänen L; Sainio M; Saarikoski ST; Arola J; Heikkilä P; Haglund C; Husgafvel-Pursiainen K; Böhling T
    Hum Pathol; 2006 Jun; 37(6):749-54. PubMed ID: 16733217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
    Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
    Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
    Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
    Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
    Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
    Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of imprinted genes DLK1-GTL2, MEST (PEG1), ZAC (PLAGL1), and LINE-1 elements in spermatozoa of normozoospermic men, unlike H19 imprinting control regions, is not associated with idiopathic recurrent spontaneous miscarriages.
    Ankolkar M; Salvi V; Warke H; Vundinti BR; Balasinor NH
    Fertil Steril; 2013 May; 99(6):1668-73. PubMed ID: 23415968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
    Basyuk E; Coulon V; Le Digarcher A; Coisy-Quivy M; Moles JP; Gandarillas A; Journot L
    Mol Cancer Res; 2005 Sep; 3(9):483-92. PubMed ID: 16179495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
    Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
    Pagotto U; Arzberger T; Theodoropoulou M; Grübler Y; Pantaloni C; Saeger W; Losa M; Journot L; Stalla GK; Spengler D
    Cancer Res; 2000 Dec; 60(24):6794-9. PubMed ID: 11156367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation.
    Barz T; Hoffmann A; Panhuysen M; Spengler D
    Cancer Res; 2006 Dec; 66(24):11975-82. PubMed ID: 17178896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
    Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
    Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.
    Mircescu H; Wilkin F; Paquette J; Oligny LL; Decaluwe H; Gaboury L; Nolet S; Van Vliet G; Deal C
    J Pediatr; 2001 Feb; 138(2):269-73. PubMed ID: 11174629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma.
    Rutherford S; Yu Y; Rumpel CA; Frierson HF; Moskaluk CA
    Cancer Lett; 2006 May; 236(2):309-17. PubMed ID: 16054751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
    Dammann R; Schagdarsurengin U; Seidel C; Trümpler C; Hoang-Vu C; Gimm O; Dralle H; Pfeifer GP; Brauckhoff M
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.
    Mackay DJ; Coupe AM; Shield JP; Storr JN; Temple IK; Robinson DO
    Hum Genet; 2002 Feb; 110(2):139-44. PubMed ID: 11935319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
    Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
    Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.